In a complimentary one-hour webinar on October 2, WCRI Policy Analyst William Monin-Browder and External Relations Director Kathy Fisher shared key insights from the latest CompScope™ Benchmarks and Medical Benchmarks for Pennsylvania, as well as findings from the Institute’s recent drug trends study.

“This research provides valuable insights for policymakers and stakeholders in the Pennsylvania workers’ compensation system. It highlights key cost drivers, trends, and the system's performance over time, as well as comparisons with other states,” said Sebastian Negrusa, Vice President of Research at WCRI.

Topics Covered:

• The primary cost drivers in Pennsylvania’s workers’ compensation system.
• Performance comparisons between Pennsylvania and other states.
• Trends across various performance metrics in Pennsylvania’s system.
• Pennsylvania’s prescription drug payments, overall and by drug group, compared to other states.

The CompScope™ Benchmarks and Medical Benchmarks studies include data from states representing 60 percent of all workers’ compensation benefits paid nationwide, including Arkansas, California, Florida, Illinois, Indiana, Iowa, Louisiana, Massachusetts, Michigan, Minnesota, New Jersey, North Carolina, Tennessee, Texas, Virginia, and Wisconsin. The most recent results are based on claims data through March 2023, including non-COVID-19 claims from the pandemic period (March 2020–September 2022). The studies, therefore, provide a look at how the pandemic impacted non-COVID-19 workers’ compensation claims over the first three years of the pandemic.

Click here to watch a recording of the webinar. 

Click here to download a copy of the slides. 

Return to listing